SCHEMBL17921534

SCHEMBL17921534

CC1(C)c2cc3c4ccccc4c4ccccc4c3cc2-c2cc3c4ccccc4c4cc(-c5nc(-c6ccccc6)cc(-n6c7ccccc7c7ccccc76)n5)ccc4c3cc21

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 7/20 0.37
▸ MAPK1 P28482 2/20 0.37
▸ NPSR1 Q6W5P4 2/20 0.37
▸ TSHR P16473 1/20 0.37
▸ HSD17B10 Q99714 1/20 0.37
▸ HPGD P15428 7/20 0.36
▸ KMT2A Q03164 8/20 0.35
▸ MEN1 O00255 7/20 0.35
▸ ALDH1A1 P00352 6/20 0.35
▸ KDM4E B2RXH2 4/20 0.33
▸ LMNA P02545 2/20 0.33
▸ ACACA Q13085 2/20 0.32
▸ NTSR1 P30989 1/20 0.32
▸ GLA P06280 1/20 0.32
▸ TDP1 Q9NUW8 1/20 0.31
▸ L3MBTL1 Q9Y468 1/20 0.31
▸ PIK3CA P42336 1/20 0.31
▸ PDE10A Q9Y233 1/20 0.30
▸ ADORA2A P29274 1/20 0.30
▸ ADORA1 P30542 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17921531 0.92 — —
SCHEMBL23330125 0.87 MAPT (0.46) MAPTMAPK1NPSR1TSHRHSD17B10
SCHEMBL17886457 0.86 — —
SCHEMBL17878939 0.86 — —
SCHEMBL17921530 0.85 MEN1 (0.34) MAPTHPGDKMT2AMEN1ALDH1A1
SCHEMBL17921533 0.84 MEN1 (0.35) MAPTNPSR1HPGDKMT2AMEN1
SCHEMBL17989654 0.84 MAPT (0.39) MAPTMAPK1NPSR1TSHRHSD17B10
SCHEMBL14731161 0.84 MAPT (0.39) MAPTMAPK1NPSR1TSHRHSD17B10
SCHEMBL16919362 0.84 MAPT (0.39) MAPTMAPK1NPSR1TSHRHSD17B10
SCHEMBL2603585 0.84 MAPT (0.39) MAPTMAPK1NPSR1TSHRHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160204345-A1 DITRIPHENYLENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME LUMINESCENCE TECHNOLOGY CORP. (TW) 2016-07-14 — — US disclosed
US-20160204345-A1 DITRIPHENYLENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME LUMINESCENCE TECHNOLOGY CORP. (TW) 2016-07-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160204345-A1 DITRIPHENYLENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME NR2E1, NR0B1, NR2E3 MAPT 4195/4885MAPK1 2679/4885NPSR1 663/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback